InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Shrewsbury Stephen B, Directeur Médical. Insider active across 1 company, notably Impel Neuropharma INC. In total, 2 filings have been logged. History available since 21 September 2021. The latest transaction was filed on 29 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Shrewsbury Stephen B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
24,606 股@ US$1.9763.8% 占其流量Common StockSEC:0001209191-22-021673:0
14,780 股@ US$1.9736.2% 占其流量Common StockSEC:0001209191-21-057275:0
2 条申报中的 2 条
About Shrewsbury Stephen B
Stephen B. Shrewsbury is the Chief Medical Officer of IMPEL NEUROPHARMA INC. In this role, he is responsible for leading the company's medical and scientific initiatives. With deep expertise in neuropharmacology, he contributes to the innovation and development of new treatments. His leadership is essential in ensuring that IMPEL NEUROPHARMA's products meet the highest standards of safety and efficacy while supporting the company's mission to transform patients' lives.
